Paul J. Mills

Dr. Paul J. Mills


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PMPaul J. Mills
Paul J. Mills
BKBrian P. Kennedy
Brian P. Kennedy
JLJose S. Loredo
Jose S. Loredo
JDJoel E. Dimsdale
Joel E. Dimsdale
MZMichael G. Ziegler
Michael G. Ziegler
Obstructive sleep apnea (OSA) is characterized by noradrenergic activation. Nasal continuous positive airway pressure (CPAP) is the treatment of choice and has been shown to effectively reduce elevated norepinephrine (NE) levels. This study examined whether the reduction in NE after CPAP is due to an increase in NE clearance and/or a decrease of NE release rate. Fifty CPAP-naive OSA patients with an apnea-hypopnea index >15 were studied. NE clearance and release rates, circulating NE levels, urinary NE excretion, and blood pressure and heart rate were determined before and after 14 days of CPAP, placebo CPAP (CPAP administered at ineffective pressure), or oxygen supplementation. CPAP led to a significant increase in NE clearance ( P ≤ 0.01), as well as decreases in plasma NE levels ( P ≤ 0.018) and daytime ( P < 0.001) and nighttime ( P < 0.05) NE excretion. NE release rate was unchanged with treatment. Systolic ( P ≤ 0.013) and diastolic ( P ≤ 0.026) blood pressure and heart rate ( P ≤ 0.014) were decreased in response to CPAP but not in response to oxygen or placebo CPAP treatment. Posttreatment systolic blood pressure was best predicted by pretreatment systolic blood pressure and posttreatment NE clearance and release rate ( P < 0.01). The findings indicate that one of the mechanisms through which CPAP reduces NE levels is through an increase in the clearance of NE from the circulation.

24 October 2017 in JAMA
Verified
Journal Article
Open access
PDF file
PMPaul J. Mills
Paul J. Mills
IKIzabela Kania-Korwel
Izabela Kania-Korwel
JFJohn Fagan
John Fagan
LMLinda K. McEvoy
Linda K. McEvoy
GLGail A. Laughlin
Gail A. Laughlin
EBElizabeth Barrett-Connor
Elizabeth Barrett-Connor
The herbicide Roundup is sprayed onto genetically modified crops and applied as a desiccant to most small non–genetically modified grains. Use of this herbicide has increased since 1994 when genetically modified crops were introduced in the United States. Glyphosate, the primary ingredient in the herbicide, is found in these crops at harvest.1 Environmental exposure through dietary intake of these crops has potential adverse health effects and can be assessed by measuring urinary excretion.2-4 We measured excretion levels of glyphosate and its metabolite aminomethylphosphonic acid (AMPA) in participants from the Rancho Bernardo Study (RBS) of Healthy Aging.

1 March 2015 in Spirituality in Clinical Practice
Verified
Journal Article
Open access
PMPaul J. Mills
Paul J. Mills
LRLaura Redwine
Laura Redwine
KWKathleen Wilson
Kathleen Wilson
MPMeredith A. Pung
Meredith A. Pung
KCKelly Chinh
Kelly Chinh
DCDeepak Chopra
Deepak Chopra
Spirituality and gratitude are associated with wellbeing. Few if any studies have examined the role of gratitude in heart failure (HF) patients or whether it is a mechanism through which spirituality may exert its beneficial effects on physical and mental health in this clinical population. This study examined associations bet ween gratitude, spiritual wellbeing, sleep, mood, fatigue, cardiac-specific self-efficacy, and inflammation in 186 men and women with Stage B asymptomatic HF (age 66.5 years ±10). In correlational analysis, gratitude was associated with better sleep (r=-.25, p<0.01), less depressed mood (r=-.41, p<0.01), less fatigue (r=-.46, p<0.01), and better self-efficacy to maintain cardiac function (r=.42, p<0.01). Patients expressing more gratitude also had lower levels of inflammatory biomarkers (r=-.17, p<0.05). We further explored relationships among these variables by examining a putative pathway to determine whether spirituality exerts its beneficial effects through gratitude. We found that gratitude fully mediated the relationship between spiritual wellbeing and sleep quality (z=−2.35, SE=.03, p=.02) and also the relationship between spiritual wellbeing and depressed mood (z=−4.00, SE=.075, p<.001). Gratitude also partially mediated the relationships between spiritual wellbeing and fatigue (z=−3.85, SE=.18, p<.001), and between spiritual wellbeing and self-efficacy (z=2.91, SE=.04, p=.003). In sum, we report that gratitude and spiritual wellbeing are related to better mood and sleep, less fatigue, and more self-efficacy, and that gratitude fully or partially mediates the beneficial effects of spiritual wellbeing on these endpoints. Efforts to increase gratitude may be a treatment for improving wellbeing in HF patients’ lives and be of potential clinical value.

1 June 2007 in SLEEP
Verified
Journal Article
Open access
PDF file
PMPaul J. Mills
Paul J. Mills
Roland von KänelRoland von Känel
Roland von Känel
DNDaniel Norman
Daniel Norman
LNLoki Natarajan
Loki Natarajan
MZMichael G. Ziegler
Michael G. Ziegler
JDJoel E. Dimsdale
Joel E. Dimsdale
Inflammation is relatively common in individuals with a sleep disorder and is associated with quality of sleep. The purpose of this study was to examine whether inflammation is associated with quality of sleep in healthy individuals. Observational study in a General Clinical Research Center. This study characterized inflammation and polysomnographically verified sleep in 124 African American and Caucasian American women and men without a sleep disorder. Circulating levels of 3 markers and/or mediators of inflammation known to be elevated in sleep disorders and in cardiovascular disease were determined (interleukin-6 [IL-6] endothelin-1 [ET-1], soluble intercellular adhesion molecule-1 [sICAM-1]). Sleep was characterized by polysomnography. Multiple linear regression analyses showed that increasing age, male sex, and African American ethnicity were independently associated with poorer sleep. After controlling for these variables, higher levels of ET-1 were independently associated with greater sleep latency (P ≤ 0.01), greater rapid eye movement (REM) latency (P ≤ 0.01), more slow wave sleep (P ≤ 0.05), and less stage 1 sleep (P ≤ 0.01). Higher IL-6 levels were independently associated with greater REM latency (P ≤ 0.05). The findings suggest that, in individuals without a known sleep disorder, ET-1, a potent vasoconstrictor and mediator of inflammation, is associated with more deep sleep, whereas both ET-1 and IL-6 are associated with increased latency of sleep and of REM. The findings underscore the complex relationships between peripheral markers of inflammation and sleep.

1 April 2005 in Biological Psychology
Verified
Journal Article
Closed access
PMPaul J. Mills
Paul J. Mills
BPBarbara Parker
Barbara Parker
JDJoel E. Dimsdale
Joel E. Dimsdale
GSGeorgia Robins Sadler
Georgia Robins Sadler
SASonia Ancoli-Israel
Sonia Ancoli-Israel

1 April 2006 in The American Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
BMBrent T Mausbach
Brent T Mausbach
KAKirstin Aschbacher
Kirstin Aschbacher
TPThomas L. Patterson
Thomas L. Patterson
SASonia Ancol-Israel
Sonia Ancol-Israel
Roland von KänelRoland von Känel
Roland von Känel
IGIgor Grant
Igor Grant